Navigation Links
Novel handheld device detects anthrax with outstanding accuracy and reliability
Date:6/25/2009

Baltimore, MD, and Christchurch, NZ June 25, 2009 Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker (pronounced "seeker") portable bacterial detection device in discriminating between anthrax spores and similar-looking hoax substances. The data show that in over two weeks of testing at the Midwest Research Institute in Florida, the company's Ceeker scanner accurately identified 100% of the anthrax samples used and was correct in 95% of tests involving hoax substances. These test results are consistent with similar results produced last year by a New Zealand forensic testing agency, Environmental Science and Research (ESR).

"We knew that our innovative Ceeker is capable of producing outstanding results in distinguishing between anthrax and look-alike hoax substances, and now we have definitive data confirming its performance," said Andrew Rudge, Ph.D., Chief Executive Officer of Veritide. "Even better, these extraordinary results were generated by a small portable handheld system that requires no special skills or training to operate and that can produce a result within minutes, enabling first responders to rapidly determine whether the situation is a nuisance or a major threat to public health."

The Ceeker employs optical detection technology developed at New Zealand's University of Canterbury. It uses ultraviolet light and special algorithms to detect bacterial spores and provides test results within minutes, without the need for wet chemistry or analytic processes that can be difficult to handle in the field. The Ceeker is capable of producing test results from very small amounts of sample and does not consume or destroy the sample being tested, allowing it to be re-analyzed later for forensic applications.

In contrast, existing dete
'/>"/>

Contact: Barbara Lindheim
212-918-4650
BioCom Partners
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. International collaboration by scientists culminates in novel ion channels database
2. UC Davis grant zeroes in on novel asthma diagnosis and treatment
3. Novel vaccine approach offers hope in fight against HIV
4. ExcellGene and Khner achieved milestone in development of novel 250 Liter mammalian cell culture bioreactors
5. Study finds novel genetic risk factors for kidney disease
6. Novel antibody prevents infection by hepatitis C virus
7. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
8. Novel lung cancer vaccine shows promise in fighting early-stage lung cancer
9. MIT: Novel needle could cut medical complications
10. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
11. Novel electric signals in plants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...LLEY, Calif., Oct. 19 Spectros, de...sing and imaging devices which shed light on life-...signed exclusive distribution deals for both its T...markets covered include Australia, New Zealand, T...iname, Italy, France, Spain, Portugal, Poland, Gre...
(Date:11/4/2009)...., Oct. 21 What,s the cost of savi...idental death resulting from prescription medicati...intentions, however, may be unaware that the lock-...eens from the ticking timebomb of prescription dru...emium-quality medical supplies, has formed an excl...
(Date:11/4/2009)...HILL Scientists at the University of North Caroli...rsity of California, San Francisco have developed ...ew target diseases for existing drugs. , The res...pares how similar the structures of all known drug...-- known as ligands -- of disease targets within t...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 1PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 2PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target com 54167 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 1Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 2Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 3Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 4Video 3A People With Pain Healthcare Providers Sound Off in First Ever Online Talk Show About Pain 54162 5BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 1BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 2BrainScope 28TM 29 Receives FDA Clearance for Portable EEG Device 54157 3
...ew study by researchers from Columbia University,s...the most challenging issues in infant health and p... countries. In these settings, HIV-infected mothe...their infants, they should exclusively breast-feed...fter birth. But according to the study conducted i...
... Pennsylvania State University College of Medicine...fficacy of imiquimod, a clinically important immun...tumor activity, is dependent on the Opioid Growth ...on. This discovery, reported in the August 08 iss...s new insights into a widely used drug that may le...
...- Scientists at Harvard University and the Univers...lution is strongly shaped by genes, efforts to pre...Their study also suggests that the cost of errors ...teins themselves, rather than the loss of function...ng-lived cells, like neurons, and cause neurodegen...
Other Biology News:Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3
(Date:11/6/2009)...mber 6 EUCODIS Bioscience, a compa...keting enzymes for the,chemical industry announced...nt with Bio Sidus, the leading biopharmaceutical c...gives EUCODIS Bioscience exclusive access - for th...oprietary collection of,psychrophilic bacteria str...
(Date:11/6/2009)...PRNewswire/ -- Intarcia Therapeutics, Inc. deliver...#174; continuous delivery of exenatide) program fo...nual Diabetes Technology Meeting in San Francisco,...prnh/20050301/SFTU126LOGO ) ,, Continuous Sub...s Plasma Glucose, HbA1c and Reduces Weight in a 28...
(Date:11/5/2009)... The endangered black-footed ferre...This rare carnivore feeds on prairie dogs. The p...en entire population die-offs in towns occur. The...ented a ferret breeding program and has been relea...native habitat. Unfortunately, plague can sweep t...
(Date:11/5/2009)...ay, November 5, 2009 at 4:30 p.m. Eastern Time ,...irstCall/ - OncoGenex Pharmaceuticals, Inc. ("Onco...ported unaudited financial results for the third q...d reviewed the Company,s highlights for the third ...results reflect the operations of OncoGenex Techno...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...nference Call To Be Held Tuesday, April 1, 2008 At...ylight Time, HOPKINTON, Mass., March 31 Alseres,...ted consolidated financial,results for the year en...ogo: http://www.newscom.com/cgi-bin/prnh/20070608...linical, regulatory, pipeline and,business accompl...
...rst Quarter 2008 Earnings Conference Call Thursday...m. U.S. EDT, FRAZER, Pa., March 31 Cephalon, In...terly earnings conference call,covering first quar...y 1,2008., May 1, 2008 S... distributed by PRNewswire 4:50 p.m. EDT To pa...
... Fiscal year Revenue Increased 51.9% to $33.2 Mill....3% to $12.8 Million, -- The Company Provides G...K and HAIKOU, Hainan, China, March 31,/Xinhua-PRNe..."China,Pharma") (OTC Bulletin Board: CPHI) which d...nded bio-pharmaceutical products in China, today,a...
Other Biology Technology:Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 2Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 3Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 4Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 5Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 6Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 7Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 8Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 9Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 2China Pharma Holdings, Inc. Announces Record 2007 Year End Results 3China Pharma Holdings, Inc. Announces Record 2007 Year End Results 4China Pharma Holdings, Inc. Announces Record 2007 Year End Results 5China Pharma Holdings, Inc. Announces Record 2007 Year End Results 6China Pharma Holdings, Inc. Announces Record 2007 Year End Results 7China Pharma Holdings, Inc. Announces Record 2007 Year End Results 8China Pharma Holdings, Inc. Announces Record 2007 Year End Results 9China Pharma Holdings, Inc. Announces Record 2007 Year End Results 10China Pharma Holdings, Inc. Announces Record 2007 Year End Results 11
Helios Gene Gun Low-Pressure System, 100-120 V from Bio-Rad
500 Optimization Kit, PDS-1000 He and Hepta systems from Bio-Rad
... Arrays can be used to test the crossreactivity of...t are commonly used as blocking reagents or antige...ent protein preparations on a nitrocellulose membr...eactivity and species specificity, QC of purified ...
...y Life Sciences can provide custom microplate coat...plate processing equipment that dispenses and wash...date virtually any lot size of the following forma...and 12 well strips, 96 well microplate, ...
Biology Products: